# A Novel Catheter Lock Solution for Treatment of Tunneled Hemodialysis Catheter-Associated Bacteremia

> **NCT00614679** · PHASE1 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 18 (actual)

## Conditions studied

- End-Stage Renal Disease
- Hemodialysis Catheter-associated Infection

## Interventions

- **DRUG:** catheter lock solution consisting of N-acetylcystein, tigecycline and heparin

## Key facts

- **NCT ID:** NCT00614679
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-12
- **Final completion:** 2009-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00614679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00614679, "A Novel Catheter Lock Solution for Treatment of Tunneled Hemodialysis Catheter-Associated Bacteremia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00614679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*